In addition, we presented evidence showing that silencing MALAT1 is associated with reduced CD133highCD90high HCC population with suppressed HCC tumorsphere formation (Figure 5) and tumor growth in vivo (Figure 6). This evidence concerns the gene MALAT1 and hepatocellular carcinoma.